GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diva Laboratories Ltd (ROCO:4153) » Definitions » Cyclically Adjusted Book per Share

Diva Laboratories (ROCO:4153) Cyclically Adjusted Book per Share : NT$23.70 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Diva Laboratories Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Diva Laboratories's adjusted book value per share for the three months ended in Mar. 2025 was NT$16.436. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$23.70 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Diva Laboratories's average Cyclically Adjusted Book Growth Rate was -1.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Diva Laboratories was 6.80% per year. The lowest was 4.20% per year. And the median was 5.50% per year.

As of today (2025-06-01), Diva Laboratories's current stock price is NT$42.50. Diva Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was NT$23.70. Diva Laboratories's Cyclically Adjusted PB Ratio of today is 1.79.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Diva Laboratories was 2.42. The lowest was 1.06. And the median was 1.47.


Diva Laboratories Cyclically Adjusted Book per Share Historical Data

The historical data trend for Diva Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diva Laboratories Cyclically Adjusted Book per Share Chart

Diva Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.38 21.18 22.77 23.63 23.94

Diva Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.99 24.11 24.04 23.94 23.70

Competitive Comparison of Diva Laboratories's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Diva Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diva Laboratories's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diva Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Diva Laboratories's Cyclically Adjusted PB Ratio falls into.


;
;

Diva Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Diva Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=16.436/134.9266*134.9266
=16.436

Current CPI (Mar. 2025) = 134.9266.

Diva Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201506 27.695 100.684 37.114
201509 27.217 100.392 36.580
201512 28.033 99.792 37.903
201603 27.936 100.470 37.517
201606 25.401 101.688 33.704
201609 24.958 101.861 33.060
201612 23.392 101.863 30.985
201703 21.760 102.862 28.543
201706 22.523 103.349 29.405
201709 18.060 104.136 23.400
201712 17.898 104.011 23.218
201803 19.545 105.290 25.047
201806 19.959 106.317 25.330
201809 20.093 106.507 25.455
201812 19.703 105.998 25.080
201903 20.100 107.251 25.287
201906 18.673 108.070 23.314
201909 18.889 108.329 23.527
201912 18.859 108.420 23.470
202003 18.656 108.902 23.114
202006 18.905 108.767 23.452
202009 16.962 109.815 20.841
202012 16.856 109.897 20.695
202103 16.837 111.754 20.328
202106 16.886 114.631 19.876
202109 16.896 115.734 19.698
202112 16.814 117.630 19.286
202203 16.867 121.301 18.762
202206 16.567 125.017 17.880
202209 16.976 125.227 18.291
202212 17.321 125.222 18.663
202303 16.688 127.348 17.681
202306 16.918 128.729 17.733
202309 17.256 129.860 17.929
202312 17.604 129.419 18.353
202403 16.792 131.776 17.193
202406 17.372 132.554 17.683
202409 17.586 133.029 17.837
202412 17.991 133.157 18.230
202503 16.436 134.927 16.436

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Diva Laboratories  (ROCO:4153) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Diva Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=42.50/23.70
=1.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Diva Laboratories was 2.42. The lowest was 1.06. And the median was 1.47.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Diva Laboratories Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Diva Laboratories's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Diva Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Zhongshan Road, 9F, No. 351, Sector 2, Zhonghe District, New Taipei City, TWN, 235
Diva Laboratories Ltd is a Taiwan-based company that engages in the sale, manufacturing, and development of medical equipment and computer-related devices. It offers endo/surgical displays; color displays for radiology and medical imaging services; touch displays; and original design manufacturing and original equipment manufacturing solutions.

Diva Laboratories Headlines

No Headlines